Total Payments
$13,524
2024 Payments
$3,200
Companies
5
Transactions
23
Medicare Patients
1,048
Medicare Billing
$80,430
Payment Breakdown by Category
Research$7,340 (54.3%)
Consulting$3,500 (25.9%)
Other$2,540 (18.8%)
Education$98.58 (0.7%)
Food & Beverage$45.26 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,340 | 8 | 54.3% |
| Consulting Fee | $3,500 | 2 | 25.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,540 | 4 | 18.8% |
| Education | $98.58 | 7 | 0.7% |
| Food and Beverage | $45.26 | 2 | 0.3% |
Payments by Type
Research
$7,340
8 transactions
General
$6,184
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $13,447 | 19 | $0 (2024) |
| SANOFI PASTEUR INC. | $24.84 | 1 | $0 (2019) |
| Lilly USA, LLC | $20.42 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $19.42 | 1 | $0 (2020) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,200 | 1 | PFIZER INC. ($3,200) |
| 2023 | $330.00 | 1 | PFIZER INC. ($330.00) |
| 2022 | $2,540 | 4 | PFIZER INC. ($2,540) |
| 2021 | $4,782 | 5 | PFIZER INC. ($4,770) |
| 2020 | $19.42 | 1 | E.R. Squibb & Sons, L.L.C. ($19.42) |
| 2019 | $1,315 | 4 | PFIZER INC. ($1,270) |
| 2018 | $1,309 | 5 | PFIZER INC. ($1,309) |
| 2017 | $28.17 | 2 | PFIZER INC. ($28.17) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | PFIZER INC. | IBRANCE (Drug) | — | In-kind items and services | $3,200.00 | Research |
| Study: IBRANCE CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 05/10/2023 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM | ||||||
| 08/30/2022 | PFIZER INC. | IBRANCE (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 05/03/2022 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM | ||||||
| 04/22/2022 | PFIZER INC. | — | — | In-kind items and services | $940.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM | ||||||
| 02/15/2022 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM | ||||||
| 12/10/2021 | PFIZER INC. | IBRANCE (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 12/03/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/17/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 07/08/2021 | PFIZER INC. | IBRANCE (Drug) | — | In-kind items and services | $330.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 11/23/2020 | E.R. Squibb & Sons, L.L.C. | Revlimid (Drug) | Education | Cash or cash equivalent | $19.42 | General |
| Category: Hematology | ||||||
| 09/11/2019 | SANOFI PASTEUR INC. | PENTACEL (Drug), QUADRACEL, FLUBLOK QUADRIVALENT | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: VACCINES | ||||||
| 09/07/2019 | PFIZER INC. | IBRANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $940.00 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2019 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Oncology | ||||||
| 05/14/2019 | PFIZER INC. | IBRANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $330.00 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2018 | PFIZER INC. | IBRANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $940.00 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2018 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 05/09/2018 | PFIZER INC. | IBRANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $330.00 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2018 | PFIZER INC. | BESPONSA (Biological) | Education | In-kind items and services | $10.90 | General |
| Category: ONCOLOGY | ||||||
| 01/02/2018 | PFIZER INC. | MYLOTARG (Biological) | Education | In-kind items and services | $20.05 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2017 | PFIZER INC. | MYLOTARG (Drug) | Education | In-kind items and services | $20.05 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2017 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PALBOCICLIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,140 | 7 |
| IBRANCE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,200 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 233 | 372 | $95,455 | $19,309 |
| 2022 | 6 | 225 | 439 | $86,850 | $18,673 |
| 2021 | 8 | 232 | 462 | $71,133 | $19,946 |
| 2020 | 11 | 358 | 594 | $88,767 | $22,502 |
Total Patients
1,048
Total Services
1,867
Medicare Billing
$80,430
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 95 | 153 | $51,255 | $10,210 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 48 | $23,904 | $4,568 | 19.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $11,304 | $2,356 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $5,556 | $1,235 | 22.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 37 | 62 | $1,302 | $454.07 | 34.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 30 | 54 | $1,634 | $365.28 | 22.4% |
| 82565 | Blood creatinine level | Office | 2023 | 16 | 25 | $500.00 | $120.48 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 111 | 204 | $64,668 | $13,843 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 23 | $10,718 | $2,509 | 23.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $6,479 | $1,287 | 19.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 32 | 86 | $2,602 | $635.95 | 24.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 36 | 83 | $1,743 | $236.40 | 13.6% |
| 82565 | Blood creatinine level | Office | 2022 | 17 | 32 | $640.00 | $161.59 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 101 | 194 | $48,888 | $12,968 | 26.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 15 | 15 | $8,100 | $2,141 | 26.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 15 | 17 | $6,052 | $1,855 | 30.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 11 | 15 | $1,860 | $1,184 | 63.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 14 | 16 | $1,344 | $693.68 | 51.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 27 | 88 | $2,574 | $683.76 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 29 | 84 | $1,680 | $252.00 | 15.0% |
| 82565 | Blood creatinine level | Office | 2021 | 20 | 33 | $635.25 | $168.96 | 26.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 80 | 164 | $39,032 | $9,154 | 23.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 32 | $10,048 | $2,667 | 26.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 52 | 62 | $9,548 | $2,178 | 22.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 18 | 18 | $7,434 | $1,967 | 26.5% |
About Dr. Daniel Anderson, MD
Dr. Daniel Anderson, MD is a Hematology & Oncology healthcare provider based in Saint Paul, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710949920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Anderson, MD has received a total of $13,524 in payments from pharmaceutical and medical device companies, with $3,200 received in 2024. These payments were reported across 23 transactions from 5 companies. The most common payment nature is "" ($7,340).
As a Medicare-enrolled provider, Anderson has provided services to 1,048 Medicare beneficiaries, totaling 1,867 services with total Medicare billing of $80,430. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Saint Paul, MN
- Active Since 04/04/2006
- Last Updated 03/08/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1710949920
Products in Payments
- IBRANCE (Drug) $7,950
- PENTACEL (Drug) $24.84
- VERZENIO (Drug) $20.42
- MYLOTARG (Biological) $20.05
- MYLOTARG (Drug) $20.05
- Revlimid (Drug) $19.42
- BOSULIF (Drug) $16.24
- BESPONSA (Biological) $10.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Saint Paul
Yan Ji, M.d, Ph.d, M.D, PH.D
Hematology & Oncology — Payments: $71,539
Hematology & Oncology $71,539
Kurt Demel, Md, MD
Hematology & Oncology — Payments: $22,510
Hematology & Oncology $22,510
Christine Ding, M.d, M.D
Hematology & Oncology — Payments: $1,285
Hematology & Oncology $1,285
Dr. Sara Torgerson, D.o, D.O
Hematology & Oncology — Payments: $988.23
Hematology & Oncology $988.23
Timothy Toonen, M.d, M.D
Hematology & Oncology — Payments: $595.24
Hematology & Oncology $595.24
Dr. Bhaskar Kolla, M.d, M.D
Hematology & Oncology — Payments: $125.00
Hematology & Oncology $125.00